Viewing Study NCT03321903


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-05-04 @ 9:37 PM
Study NCT ID: NCT03321903
Status: TERMINATED
Last Update Posted: 2019-12-19
First Post: 2017-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: EPR Tumor Oximetry With CE India Ink
Sponsor: Philip Schaner
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 29880 D17008
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View